Investor enthusiasm and evolving FDA pathways are accelerating rare disease drug development, with ultrarare conditions like ...
Clinical data disclosed in November 2025 to be presented at medical meeting with new supportive translational data for both programsVispa-cel (CB-010) ANTLER phase 1 translational and clinical data ...
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Feb. 3, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company ...
Nine recommendations for extending therapeutic indications reflect ongoing lifecycle management and utility expansion of ...
India Today on MSN
Cancer vaccines: shot in the arm to prevent the deadly disease?
On this World Cancer Day, we look at where research and availability stand for cancer vaccines.
Terremoto Biosciences is a company making waves in the drug development world. They’re using a pretty cool approach to create new medicines, focusing on how molecules interact at a chemical level.
Researchers at Ben-Gurion University of the Negev (BGU) have discovered that a gene long known for shaping the skin's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results